Lylach Haizler-Cohen, Haleema Saeed, Valencia Quiett, Gurpinder Kaur, Eshetu A Tefera, Samrawit Gizaw, Richard Verstraete, Michael Auerbach, Nicholas Hazen
{"title":"网织红细胞血红蛋白当量在筛查妊娠期铁缺乏症中的实用性。","authors":"Lylach Haizler-Cohen, Haleema Saeed, Valencia Quiett, Gurpinder Kaur, Eshetu A Tefera, Samrawit Gizaw, Richard Verstraete, Michael Auerbach, Nicholas Hazen","doi":"10.1055/a-2419-9404","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong> Ferritin, commonly used for diagnosing iron deficiency (ID) in pregnancy, is limited by high cost and false elevations during inflammation. Reticulocyte hemoglobin equivalent (Ret-He), an alternative marker for ID, is unaffected by inflammation and analyzed on the same collection tube as the standard complete blood count (CBC). We aimed to determine the accuracy of Ret-He in detecting ID in pregnancy compared to ferritin in a U.S.</p><p><strong>Cohort: </strong></p><p><strong>Study design: </strong> This prospective cohort study enrolled 200 pregnant participants, recruited in any trimester if a CBC was drawn as part of routine prenatal care. For those who agreed to participate, Ret-He and ferritin were collected concurrently with the CBC. ID was defined as ferritin level below 30 ng/mL. Patients were classified into three groups based on hemoglobin and ferritin results to determine the severity of ID: no ID, ID alone, and ID anemia (IDA). Four participants with anemia but normal ferritin were excluded. Receiver operating curve analysis, including the area under the curve (AUC), was performed to assess the accuracy of Ret-He in detecting ID. A one-way ANOVA (analysis of variance) with post-hoc analysis was used to compare differences in Ret-He between the three groups of ID severity.</p><p><strong>Results: </strong> The prevalence of ID in our cohort was 82% (161/196). The AUC for Ret-He was 0.65 (95% confidence interval: 0.55-0.75), indicating suboptimal discrimination between patients with and without ID. Ret-He was significantly different among the three groups (<i>p</i> < 0.001). In post-hoc analysis, Ret-He was significantly lower in the IDA group compared to the ID group (<i>p</i> < 0.001) but there was only a trend of lower Ret-He in the ID group compared to the non-ID group (<i>p</i> = 0.38).</p><p><strong>Conclusion: </strong> Ret-He has low accuracy in diagnosing ID in pregnancy. It may be useful in detecting severe ID resulting in anemia but not a mild iron-deficient state resulting in ID only.</p><p><strong>Key points: </strong>· The prevalence of ID in our cohort was 82%.. · Ret-He has low accuracy in diagnosing ID in pregnancy.. · Ferritin is preferable when readily available..</p>","PeriodicalId":7584,"journal":{"name":"American journal of perinatology","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Utility of Reticulocyte Hemoglobin Equivalent in Screening for Iron Deficiency in Pregnancy.\",\"authors\":\"Lylach Haizler-Cohen, Haleema Saeed, Valencia Quiett, Gurpinder Kaur, Eshetu A Tefera, Samrawit Gizaw, Richard Verstraete, Michael Auerbach, Nicholas Hazen\",\"doi\":\"10.1055/a-2419-9404\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong> Ferritin, commonly used for diagnosing iron deficiency (ID) in pregnancy, is limited by high cost and false elevations during inflammation. Reticulocyte hemoglobin equivalent (Ret-He), an alternative marker for ID, is unaffected by inflammation and analyzed on the same collection tube as the standard complete blood count (CBC). We aimed to determine the accuracy of Ret-He in detecting ID in pregnancy compared to ferritin in a U.S.</p><p><strong>Cohort: </strong></p><p><strong>Study design: </strong> This prospective cohort study enrolled 200 pregnant participants, recruited in any trimester if a CBC was drawn as part of routine prenatal care. For those who agreed to participate, Ret-He and ferritin were collected concurrently with the CBC. ID was defined as ferritin level below 30 ng/mL. Patients were classified into three groups based on hemoglobin and ferritin results to determine the severity of ID: no ID, ID alone, and ID anemia (IDA). Four participants with anemia but normal ferritin were excluded. Receiver operating curve analysis, including the area under the curve (AUC), was performed to assess the accuracy of Ret-He in detecting ID. A one-way ANOVA (analysis of variance) with post-hoc analysis was used to compare differences in Ret-He between the three groups of ID severity.</p><p><strong>Results: </strong> The prevalence of ID in our cohort was 82% (161/196). The AUC for Ret-He was 0.65 (95% confidence interval: 0.55-0.75), indicating suboptimal discrimination between patients with and without ID. Ret-He was significantly different among the three groups (<i>p</i> < 0.001). In post-hoc analysis, Ret-He was significantly lower in the IDA group compared to the ID group (<i>p</i> < 0.001) but there was only a trend of lower Ret-He in the ID group compared to the non-ID group (<i>p</i> = 0.38).</p><p><strong>Conclusion: </strong> Ret-He has low accuracy in diagnosing ID in pregnancy. It may be useful in detecting severe ID resulting in anemia but not a mild iron-deficient state resulting in ID only.</p><p><strong>Key points: </strong>· The prevalence of ID in our cohort was 82%.. · Ret-He has low accuracy in diagnosing ID in pregnancy.. · Ferritin is preferable when readily available..</p>\",\"PeriodicalId\":7584,\"journal\":{\"name\":\"American journal of perinatology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-10-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of perinatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2419-9404\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of perinatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2419-9404","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
铁蛋白通常用于诊断妊娠期铁缺乏症(ID),但因成本高和炎症期间的假性升高而受到限制。网织红细胞血红蛋白当量(Ret-He)是ID的替代标记物,不受炎症影响,与标准全血细胞计数(CBC)在同一采血管中进行分析。我们的目的是在美国的一个队列中确定与铁蛋白相比,Ret-He 检测妊娠期 ID 的准确性。这项前瞻性队列研究共招募了 200 名孕妇,只要在常规产前检查中抽取了全血细胞计数,他们就会在任何孕期被招募。对于同意参与的孕妇,在采集全血细胞计数的同时采集 Ret-He 和铁蛋白。ID的定义是铁蛋白水平低于30纳克/毫升。根据血红蛋白和铁蛋白结果将患者分为三组,以确定ID的严重程度:无ID、仅有ID和缺铁性贫血(IDA)。四名贫血但铁蛋白正常的患者被排除在外。为评估 Ret-He 检测 ID 的准确性,进行了接收者操作曲线分析(ROC),包括曲线下面积(AUC)。采用单因素方差分析和事后分析来比较三组 ID 严重程度之间 Ret-He 的差异。我们队列中的 ID 患病率为 82%(161/196)。Ret-He的AUC为0.65(95%置信区间为0.55-0.75),表明ID患者和非ID患者之间的区分度不理想。三组患者的 Ret-He 有明显差异(p
Utility of Reticulocyte Hemoglobin Equivalent in Screening for Iron Deficiency in Pregnancy.
Objective: Ferritin, commonly used for diagnosing iron deficiency (ID) in pregnancy, is limited by high cost and false elevations during inflammation. Reticulocyte hemoglobin equivalent (Ret-He), an alternative marker for ID, is unaffected by inflammation and analyzed on the same collection tube as the standard complete blood count (CBC). We aimed to determine the accuracy of Ret-He in detecting ID in pregnancy compared to ferritin in a U.S.
Cohort:
Study design: This prospective cohort study enrolled 200 pregnant participants, recruited in any trimester if a CBC was drawn as part of routine prenatal care. For those who agreed to participate, Ret-He and ferritin were collected concurrently with the CBC. ID was defined as ferritin level below 30 ng/mL. Patients were classified into three groups based on hemoglobin and ferritin results to determine the severity of ID: no ID, ID alone, and ID anemia (IDA). Four participants with anemia but normal ferritin were excluded. Receiver operating curve analysis, including the area under the curve (AUC), was performed to assess the accuracy of Ret-He in detecting ID. A one-way ANOVA (analysis of variance) with post-hoc analysis was used to compare differences in Ret-He between the three groups of ID severity.
Results: The prevalence of ID in our cohort was 82% (161/196). The AUC for Ret-He was 0.65 (95% confidence interval: 0.55-0.75), indicating suboptimal discrimination between patients with and without ID. Ret-He was significantly different among the three groups (p < 0.001). In post-hoc analysis, Ret-He was significantly lower in the IDA group compared to the ID group (p < 0.001) but there was only a trend of lower Ret-He in the ID group compared to the non-ID group (p = 0.38).
Conclusion: Ret-He has low accuracy in diagnosing ID in pregnancy. It may be useful in detecting severe ID resulting in anemia but not a mild iron-deficient state resulting in ID only.
Key points: · The prevalence of ID in our cohort was 82%.. · Ret-He has low accuracy in diagnosing ID in pregnancy.. · Ferritin is preferable when readily available..
期刊介绍:
The American Journal of Perinatology is an international, peer-reviewed, and indexed journal publishing 14 issues a year dealing with original research and topical reviews. It is the definitive forum for specialists in obstetrics, neonatology, perinatology, and maternal/fetal medicine, with emphasis on bridging the different fields.
The focus is primarily on clinical and translational research, clinical and technical advances in diagnosis, monitoring, and treatment as well as evidence-based reviews. Topics of interest include epidemiology, diagnosis, prevention, and management of maternal, fetal, and neonatal diseases. Manuscripts on new technology, NICU set-ups, and nursing topics are published to provide a broad survey of important issues in this field.
All articles undergo rigorous peer review, with web-based submission, expedited turn-around, and availability of electronic publication.
The American Journal of Perinatology is accompanied by AJP Reports - an Open Access journal for case reports in neonatology and maternal/fetal medicine.